Get short, timely messages from Novartis.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @Novartis.

Get updates via SMS by texting follow Novartis to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

Novartis

  1. ENESTcmr data is being presented tomorrow at #ASCO12 in E354a
  2. Spread the #advancedBC story: bit.ly/KP1F3b #MBCInspire
  3. Medical experts, researchers & advocacy groups aspire to advancing the science in CML, learn more bit.ly/HeYX2d
  4. Novartis is a leader in oncology with 6 approved drugs and one of the largest R&D programs; follow us to learn more
  5. Novartis continues to research ways to control tumor growth in #advancedBC #ASCO12
  6. #DidYouKnow there are many disease pathways associated with #advancedBC bit.ly/KNX6GN #ASCO12
  7. Path in CML, our ongoing commitment to #CML patients to one day live treatment-free. Watch how: bit.ly/HeYX2d
  8. New study data on patients with advanced solid tumors happening now #ASCO12; abstract #3003 @ E Arie Crown Theater
  9. Hear the untold story of #advancedBC patients: bit.ly/KP1F3b #MBCInspire
  10. Experts weigh in about the latest data in #CML. Visit now bit.ly/qSdG84
  11. Today during #ASCO12: Phase II study on investigational compound in multiple myeloma, abstract #8012 @ E354a
  12. #advancedBC is different from early stages of breast cancer. Learn about the complexity of the disease: bit.ly/KNX6GN #ASCO12
  13. Learn about the challenges that #advancedBC patients face every day bit.ly/JYHy1i #MBCInspire
  14. Inspiring #advancedBC patients share their untold stories bit.ly/KP1F3b #MBCInspire
  15. Novartis Oncology pipeline has more than 25 innovative new molecular entities
  16. Want to hear a researcher’s perspective on #CML? Visit now bit.ly/qSdG84
  17. #DidYouKnow top countries represented at #ASCO12 include USA, Germany & Japan? Track #ACSCO12 via the @Novartis feed
  18. Check out the BOLERO-2 #advancedBC poster presented in S Hall A2 #ASCO12 bit.ly/KjXwCH
  19. #CML is responsible for up to 15% of all adult cases of leukemia. Connect w/ others living w/ #CML at cmlearth.com
  20. BOLERO-2 #advancedBC update starting now in S Hall A2 bit.ly/KjXwCH #ASCO12